Salt Lake City, Utah (PRWEB) March 25, 2014
The Cholangiocarcinoma Foundation announced today that Donna Mayer has been appointed Acting Executive Director. Donna has developed and implemented innovative programs and services for non-profit organizations including DIA and the Hepatitis B Foundation. She has a long history serving as an advocate providing support and information to patients and the allied healthcare community worldwide.
CCF President, Stacie Lindsey, described the appointment as a very significant step for the organization. “Donna has a successful track record of implementing effective global strategies and we are looking forward to her leadership and guidance.” She added, “We would like to thank Kim Crittenden for her service to the foundation this year and moving us forward on several important areas. We wish her well in her future endeavors.”
Donna is a member of the Women Business Leaders of the U.S. Health Care Industry Foundation and a long-time volunteer with the Bucks County and Keystone Crisis Intervention Teams. Her collaborations with other organizations include the Patient Centered Outcomes Research Institute, Clinical Trials Transformation Initiative, National Organization for Rare Disorders, International Association of Patient Organizations, and regulatory agencies such as the Food and Drug Administration and European Medicines Agency.
In a recent interview, Donna shared that she looks forward to building a strong foundation to assure a solid infrastructure and continued growth with an eye on delivering quality programs and services to constituents worldwide. "My goal is to establish strategic partnerships with global stakeholders — particularly among the regulatory, scientific, industry, academic, and patient communities in order to drive transformation and truly meet the mission of The Cholangiocarcinoma Foundation."
The Cholangiocarcinoma Foundation is a 501(c) (3) non-profit organization. Its vision is to bring about a CURE for Cholangiocarcinoma through Collaboration, Understanding, Research, and Education.